TY - JOUR
T1 - From scientific evidence to clinical practice: Treatment regimens for macular edema secondary to retinal vein occlusion
AU - Abraldes, M. J.
AU - Zapata, M. A.
AU - Gómez-Ulla, F.
AU - García-Arumí, J.
PY - 2012/12/1
Y1 - 2012/12/1
N2 - Retinal vein occlusion (RVO) is the second most common cause of retinal vascular disease after diabetic retinopathy. Despite the existence of several possible treatment options, none was entirely satisfactory and many patients suffered irreversible visual loss. As a result of the BRAVO, CRUISE and GENEVA trials, ranibizumab and the intravitreal biodegradable implants of dexamethasone has recently been approved by the US Food and Drug Administration and the European Medicines Agency for the treatment of RVO secondary edema. In this paper we begin by describing the current treatment options for RVO associated macular edema and continue with the description of the treatment regimen with ranibizumab. © 2012 Sociedad Española de Oftalmoloǵa. Publicado por Elsevier España, S.L. Todos los derechos reservados.
AB - Retinal vein occlusion (RVO) is the second most common cause of retinal vascular disease after diabetic retinopathy. Despite the existence of several possible treatment options, none was entirely satisfactory and many patients suffered irreversible visual loss. As a result of the BRAVO, CRUISE and GENEVA trials, ranibizumab and the intravitreal biodegradable implants of dexamethasone has recently been approved by the US Food and Drug Administration and the European Medicines Agency for the treatment of RVO secondary edema. In this paper we begin by describing the current treatment options for RVO associated macular edema and continue with the description of the treatment regimen with ranibizumab. © 2012 Sociedad Española de Oftalmoloǵa. Publicado por Elsevier España, S.L. Todos los derechos reservados.
KW - Angiography
KW - Antiangiogenic drugs
KW - Intravitreal implants of dexamethasone
KW - Macular edema
KW - Photocoagulation
KW - Ranibizumab
KW - Retinal vein occlusion
UR - https://www.scopus.com/pages/publications/84873376542
U2 - 10.1016/S0365-6691(12)70052-7
DO - 10.1016/S0365-6691(12)70052-7
M3 - Article
SN - 0365-6691
VL - 87
SP - 54
EP - 62
JO - Archivos de la Sociedad Espanola de Oftalmologia
JF - Archivos de la Sociedad Espanola de Oftalmologia
IS - SUPPL.1
ER -
